6-109145277-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001271852.3(CEP57L1):c.56G>A(p.Arg19Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000387 in 1,606,478 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001271852.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEP57L1 | NM_001271852.3 | c.56G>A | p.Arg19Lys | missense_variant | 2/11 | ENST00000517392.6 | NP_001258781.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEP57L1 | ENST00000517392.6 | c.56G>A | p.Arg19Lys | missense_variant | 2/11 | 2 | NM_001271852.3 | ENSP00000427844.1 |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 151894Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000144 AC: 36AN: 249756Hom.: 0 AF XY: 0.000148 AC XY: 20AN XY: 135050
GnomAD4 exome AF: 0.000399 AC: 581AN: 1454584Hom.: 1 Cov.: 28 AF XY: 0.000398 AC XY: 288AN XY: 724010
GnomAD4 genome AF: 0.000263 AC: 40AN: 151894Hom.: 0 Cov.: 32 AF XY: 0.000229 AC XY: 17AN XY: 74170
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 30, 2021 | The c.56G>A (p.R19K) alteration is located in exon 4 (coding exon 1) of the CEP57L1 gene. This alteration results from a G to A substitution at nucleotide position 56, causing the arginine (R) at amino acid position 19 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at